QA0.011
Neurodevelopmental disorders, related to pathogenic variants in glutamate receptor genes
Clinical Classification Guidelines
Medical Intelligence & Overview
Neurodevelopmental disorders associated with pathogenic variants in glutamate receptor genes are a group of conditions affecting brain development and function. These disorders can impact various areas such as cognition, behavior, communication, and motor skills. They are linked to genetic changes that influence how glutamate receptors work. Glutamate is the main excitatory neurotransmitter in the brain, essential for learning, memory, and brain plasticity. When genetic mutations disrupt glutamate receptor function, it can lead to developmental challenges and neurological symptoms.
Causes & Symptoms
Clinical Causes: Genetic mutations in glutamate receptor genes, which may be inherited or arise spontaneously Pathogenic variants altering the structure or function of glutamate receptors Potential interactions with environmental factors, though primary cause is genetic
Key Symptoms: Intellectual disability or learning difficulties Speech and language delays or communication challenges Motor coordination issues or delays in achieving motor milestones Behavioral problems, such as hyperactivity, anxiety, or social difficulties Seizures or abnormal electrical activity in the brain Sensory processing issues, including hypersensitivity or hyposensitivity
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive review of medical and developmental history, alongside genetic testing to identify mutations in glutamate receptor genes. Additional assessments, including neurological exams, developmental evaluations, and neuroimaging, may be used to rule out other causes and better understand the extent of neurological impact. Molecular genetic testing, such as whole-exome sequencing, is key to detecting specific pathogenic variants contributing to the disorder.
Treatment Protocols: Educational therapies tailored to individual learning needs Speech and language therapy to improve communication skills Occupational therapy to enhance motor skills and sensory processing Behavioral therapy to manage specific behavioral challenges Medications to control seizures or mood-related symptoms Supportive services and interventions to promote social and functional independence
Clinical Advice & FAQs
Billing Guidance
Is QA0.011 a billable ICD-10 code?
Yes, QA0.011 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report QA0.011?
Clinical documentation must specify the nature of Neurodevelopmental disorders, related to pathogenic variants in glutamate receptor genes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference